[HTML][HTML] Reactive oxygen species in inflammation and tissue injury

SM Rizwan, P ReddySekhar… - Antioxidants & redox …, 2014 - liebertpub.com
Reactive oxygen species (ROS) are key signaling molecules that play an important role in
the progression of inflammatory disorders. An enhanced ROS generation by …

Psoriasis: keratinocytes or immune cells–which is the trigger?

F Benhadou, D Mintoff, V Del Marmol - Dermatology, 2019 - karger.com
Background: Psoriasis is a common, chronic inflammatory skin disorder, which can
significantly impact quality of life. Despite major breakthroughs in our understanding of the …

Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis

B Nedoszytko, M Sokołowska-Wojdyło… - … in Dermatology and …, 2014 - termedia.pl
Chemokines are signaling peptides which regulate cell trafficking and provide control of the
tissue-specific cell homing. In the skin, chemokines are secreted both by the resident cells …

Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study

P Gisondi, G Tessari, A Conti… - British Journal of …, 2007 - academic.oup.com
Background Psoriasis is a chronic inflammatory disease associated with an increased
cardiovascular risk. Metabolic syndrome is a significant predictor of cardiovascular events …

[HTML][HTML] Nonalcoholic fatty liver disease-A multisystem disease?

I Mikolasevic, S Milic, TT Wensveen, I Grgic… - World Journal of …, 2016 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is one of the most common comorbidities
associated with overweight and metabolic syndrome (MetS). Importantly, NAFLD is one of its …

Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution

A Kuek, BL Hazleman, AJK Östör - Postgraduate medical journal, 2007 - academic.oup.com
Targeted biologic therapies have revolutionised treatment of immune-mediated
inflammatory diseases (IMIDs) due to their efficacy, speed of onset and tolerability. The …

Psoriatic arthritis

DD Gladman - Moderate-to-Severe Psoriasis, 2008 - taylorfrancis.com
The occurrence of arthritis in patients with psoriasis has been recognized since the 19th
century. However, psoriatic arthritis (PsA) was identified as a distinct entity primarily as a …

Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients

M Wakkee, HB Thio, EP Prens, EJG Sijbrands… - Atherosclerosis, 2007 - Elsevier
Psoriasis is a chronic inflammatory skin disease that is associated with an increased
cardiovascular risk profile. The systemic inflammation present in psoriasis, various systemic …

[HTML][HTML] Childhood guttate psoriasis: An updated review

AKC Leung, B Barankin, JM Lam, KF Leong - Drugs in context, 2023 - ncbi.nlm.nih.gov
Background Guttate psoriasis is common and affects 0.5–2% of individuals in the paediatric
age group. This review aims to familiarize physicians with the clinical manifestations …

A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis

J Brück, R Dringen, A Amasuno… - Experimental …, 2018 - Wiley Online Library
Fumaric acid esters (FAEs) such as dimethylfumarate (DMF) are used for the treatment of
adults with moderate‐to‐severe psoriasis. The mode of action of FAEs is complex. Here, we …